Stillwater Area Public Schools board approves smaller premium increase, limits GLP‑1 coverage to medical uses

The Stillwater Area Public Schools Board of Education voted at a special meeting to set next year’s health insurance renewal at a 13% premium increase and to continue coverage of GLP‑1 class medications for diabetes and cardiovascular uses while excluding coverage for weight‑loss purposes.

Board members said the decision balanced fiscal pressures on the district’s insurance fund against wide public comment and staff and union input. Chris, a district staff member presenting the renewal, told the board, “we are finding ourselves, short 3 and a half million dollars in, revenue to support our plan.” The board approved the motion by voice vote; the meeting record shows one nay and unspecified abstentions.

The vote followed a presentation from district staff and the insurance consultant, Aaron Casper, laying out claims trends and premium scenarios. Staff reported projected claims and fixed costs of about $24,000,000 against anticipated premium income of roughly $20,000,000–$20,500,000, producing the shortfall the district must address.

Why it matters: Stillwater’s insurance trust has faced rising prescription and medical claims, and the board cited the need to limit premium growth to avoid deeper budget impacts on classroom programs. The district argued that excluding GLP‑1 coverage for weight loss would reduce the projected increase while preserving treatment for medically necessary conditions.

Most consequential facts: Under the plan presented, current monthly premiums are $8.13 for single coverage and $23.19 for family coverage. An 18% renewal would raise those to $9.59 (single) and $27.37 (family); the 13% renewal chosen by the board raises premiums to $9.18 (single) and $26.21 (family), according to staff slides shown at the meeting.

Staff and committee input: The district’s insurance committee — made up of bargaining‑unit representatives and a retiree representative — recommended continuing full coverage of GLP‑1 medications. That committee, along with consultant analysis, emphasized personal health impacts described by employees and retirees during outreach. By contrast, an employee survey reached a different result: about 593 of 904 enrolled employees (roughly 66%) responded, and about 69% of respondents said they preferred discontinuing coverage for weight‑loss indications to contain costs.

Scope and scale: Staff said the plan covers roughly 3,000 people overall and that the GLP‑1 drug use driving this portion of costs is concentrated in a small subset—about 60–90 individuals—whose prescriptions account for roughly $500,000 of the plan’s spending. Staff told the board GLP‑1 medication spending has grown rapidly (a cited example showed a single medication rising 134% year over year).

Implementation and appeals: Under the board action, GLP‑1 drugs will remain covered when Blue Cross Blue Shield determines a medical indication (for example, diabetes or certain cardiovascular uses). Staff said the insurer will implement “more in‑depth screening” and utilization management, including dispensing shorter initial prescriptions, and that members can pursue Blue Cross’s standard appeals process for individual medical necessity exceptions. Staff also said that if GLP‑1 drugs are excluded for weight loss, affected members would pay out of pocket and could use FSA or other flexible spending accounts; staff noted they would check whether costs would count toward the deductible or out‑of‑pocket maximum.

Budget tradeoffs and next steps: Board members debated fiduciary responsibility and potential effects on recruitment and retention of lower‑paid employees. Staff explained the district typically maintains an 85/15 employer/employee premium split by practice and that any change to that split would be addressed through memoranda of understanding (MOUs) negotiated with bargaining units; staff said a proposed district contribution increase of 6.5 percentage points (to help offset some of the premium rise) would cost about $1.2–1.3 million and would require unit approval.

Staff emphasized time sensitivity: the district must finalize rates and MOUs before vendor deadlines to open enrollment (staff indicated an intended open enrollment start in early May) and urged the board to set rates so administration can load them into enrollment systems. The board approved the 13% renewal and the coverage limitation and directed staff to proceed with contract and enrollment steps.

Votes at a glance: The board approved the motion to adopt the 13% premium renewal and to maintain GLP‑1 coverage for medical uses but exclude coverage for weight‑loss purposes. The approval came by voice vote; the meeting record lists one recorded nay and unspecified abstentions. The board did not record a roll‑call tally or list of votes by name in the transcript.

The board adjourned after the vote; staff will return to bargaining units and finalize MOUs, enrolment materials and insurer processes in line with the board direction.